Daptomycin API Manufacturers | Suppliers | Exporters

01

Comhony Biotech

China

Fi Europe 2024

Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.

Contact Supplier

China

Virtual Booth

Digital Content

Daptomycin

About the Company : Comhony Biotech is dedicated to supplying APIs and nutraceutical ingredients to worldwide clients in the pharmaceutical and nutraceutical sectors. Leveraging its proprietary techno...

Comhony Biotech is dedicated to supplying APIs and nutraceutical ingredients to worldwide clients in the pharmaceutical and nutraceutical sectors. Leveraging its proprietary technologies, Comhony produces fermentation and semi-synthetic products targeting dermatology and antibiotics (APIs), as well as mitochondria and memory health (nutraceuticals). Comhony's manufacturing facility has received approval and confirmation from the NMPA (CFDA) for its compliance with Chinese GMP standards, which is equivalent to EU, WHO, and ICH/Q7 GMP standards.

02

Shanghai Minbiotech

China

2024 ACI Convention

Not Confirmed

Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Contact Supplier

China

Virtual Booth

Digital Content

Daptomycin

About the Company : Headquartered in Fengxian District, Shanghai Minbiotch Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs...

Headquartered in Fengxian District, Shanghai Minbiotch Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.

Corporate PDF

03

ChemWerth Inc

U.S.A

2024 ACI Convention

Not Confirmed

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Daptomycin

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.

04

EUROAPI

France

Bio-Europe 2024

Exhibiting

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Daptomycin

About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...

EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Thanks to its excellent R&D skills and six manufacturing facilities across Europe, EUROAPI guarantees API manufacturing of the highest quality to its clients in over 80 countries. Its strong innovation and R&D skills helps it to speed the development of more complex molecule segments through CDMO operations. It also offers experience in supply, regulation and quality. EUROAPI employs 3,350 people and is listed on Euronext.

05

LGM Pharma

U.S.A

BioFlorida Conference

Attending

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Daptomycin

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.

06

Rochem International Inc

U.S.A

2024 ACI Convention

Not Confirmed

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Daptomycin

About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.

07

Chongqing DaXin Pharmaceutical

China

2024 ACI Convention

Not Confirmed

Not Confirmed

13

Olon S.p.A

Italy

2024 ACI Convention

Not Confirmed

14

Sajjala Bio Labs

India

2024 ACI Convention

Not Confirmed

Sajjala Bio Labs

India

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Daptomycin

About the Company : Sajjala Bio Labs is a two year old bio pharmaceutical API production company headquartered in Hyderabad. At the moment, we commercially produce and sell Enoxaparin Sodium and L-asp...

Sajjala Bio Labs is a two year old bio pharmaceutical API production company headquartered in Hyderabad. At the moment, we commercially produce and sell Enoxaparin Sodium and L-asparaginase in the Indian market. Our pipeline of products to be launched in the calendar year 2018 include Liraglutide, Pegylated L-asparaginase, Teriparatide and Hyaluronic Acid. In addition to the production of APIs we also offer a range of R&D services including end-to-end technology transfers and contract product development services. Our infrastructure includes a WHO GMP certifies production facility with 2000 litres fermentation capacity, a DSIR recognised R&D lab, in-house Quality Control facilities and a microbiology lab and all the necessary supporting infrastructure.

Portfolio PDF

Product Web Link

15

Shenzhen Haorui

China

2024 ACI Convention

Not Confirmed

16

Synthland

China

2024 ACI Convention

Not Confirmed

17

Tecoland Corporation

U.S.A

2024 ACI Convention

Not Confirmed

18

Tocopharm Co. Limited

China

2024 ACI Convention

Not Confirmed

Tocopharm Co. Limited

China

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

China

Virtual Booth

Digital Content

Daptomycin

About the Company : Tocopharm Co. Limited, built in 2008,is an industry leader in the field of Active Pharmaceutical Ingredients(API), relative pharmaceutical intermediates, derivatives of Quinoline d...

Tocopharm Co. Limited, built in 2008,is an industry leader in the field of Active Pharmaceutical Ingredients(API), relative pharmaceutical intermediates, derivatives of Quinoline derivatives of Beta-cyclodextrin and custom synthesis services. We are specialized in exploring,researching and production of these chemicals. We are also able to provide our customers with professional services and products with high quality. Tocopharm is in possession of two R&D laboratories and two factories in mainland China. Our products are made to the strictest quality control standards and meet all government regulations. At Tocopharm, our ever increasing global presence has been achieved through world class customer service and our commitment to innovation. We work with each individual customer to develop a solution that not only meets their demands, it exceeds them.Our products have been widely sold to many countries and regions that we have established long-term stable relations of cooperation with the traders and end users all around the world and have become a solid bridge among the suppliers, traders and end users.

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

19

Xellia Pharmaceuticals ApS

Denmark

2024 ACI Convention

Not Confirmed

20

Yacht Bio-Technology

China

2024 ACI Convention

Not Confirmed

21

Zhejiang Huida Biotech

China

2024 ACI Convention

Not Confirmed

22

Zydus Lifesciences

India

2024 ACI Convention

Not Confirmed

Daptomycin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

14 USDMF

3 JDMF

7 KDMF

10 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers

40 FDA Orange Book

13 Europe

4 Canada

6 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - 350MG/VIAL

POWDER;INTRAVENOUS - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl

1 Actylis

1 Gangwal Chemicals

EXCIPIENTS BY APPLICATIONS

2 Coating Systems & Additives

2 Taste Masking

2 Thickeners and Stabilizers

1 Parenteral

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow

59 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

9 Finished Drug Prices

6 Annual Reports

MARKET PLACE

16 APIs

2 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents

2 Health Canada Patents

Filters

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

Daptomycin Manufacturers | Traders | Suppliers

POWDER;INTRAVENOUS - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons